Skip to main navigation Skip to search Skip to main content

Treatment of phantom limb pain syndrome by tisanidin

  • Ya M. Vorobeichik
  • , M. L. Kukushkin
  • , V. K. Reshetnyak
  • , A. M. Ovechkin
  • , A. V. Gnezdilov

Research output: Contribution to journalArticlepeer-review

Abstract

The authors carried out estimation of analgetic effect of tisanidin by double blind test in patients with phantom limb pain syndrome. 14 patients took the medicine in a dose of 12 mg/day and 5 patients took placebo at the same dose. Characteristics and intensity of pain were estimated in accordance with McGill pain questionnaire and visual analogue scale. Pain possessed more than one sensory characteristics in the majority of patients. Tisanidin had a significant analgetic influence on all type of phantom limb pain: "neuralgic" - acute, shooting, transitory, "causalgic" -hot, burning, searing, "cramping" pain. Pain sensation did not decrease only in one of 14 patients treated with tisanidin. The authors explain the effectivity of the drug for treatment of phantom limb pain of different sensory modality by variety of the mechanisms of its therapeutic action, the capacity to decrease the releasing of exitatory neurotransmitter amino acids and the influence on α2-adrenoceptors.

Original languageEnglish (US)
Pages (from-to)36-39
Number of pages4
JournalZhurnal Nevropatolgii i Psikhiatrii im. S S Korsakova
Volume97
Issue number3
StatePublished - 1997

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • Clinical Neurology
  • Psychiatry and Mental health

Fingerprint

Dive into the research topics of 'Treatment of phantom limb pain syndrome by tisanidin'. Together they form a unique fingerprint.

Cite this